14 Jul 2022 , 12:28 PM
The acquisition reaffirms the company’s commitment to assisting global life sciences companies in generating business value from cloud-first digital platforms and data in order to accelerate clinical trials and scale drug development, thereby positively impacting lives and achieving better health outcomes.
BASE brings domain experts with commercial, medical, digital marketing, clinical, regulatory, and quality knowledge to Infosys. BASE, backed by a team of data science experts, is at the forefront of the most recent technological developments and trends.
It has a strong focus on data and artificial intelligence, as well as the ability to bridge and integrate business logic and technology, resulting in insights for better health outcomes.
BASE, headquartered in Denmark, is one of the life sciences industry's fastest-growing technology and consulting partners. The company employs approximately 200 of the best multidisciplinary industry experts from Denmark, Switzerland, the United Kingdom, Germany, France, Italy, and a nearshore technology hub in Spain.
BASE seeks to expand its portfolio of expertise into the Consumer Health, Animal Health, MedTech, and Genomics segments in collaboration with Infosys. It works with leading life sciences software technology providers such as Veeva, IQVIA, and Salesforce.
Subject to customary closing conditions, the acquisition is expected to close in the second quarter of fiscal 2023.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.